ORKT (30) LHSW (31) GYGY (27) IFBD (33) ⌘ Pro Terminal →

BIO-key International Inc. (BKYI) — RQD Stock Rating Cockpit

$2.70 -7.85% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.66

BIO-key International Inc. (BKYI) carries a Roarable Rating of D- (Sell) with 35/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (35/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $5.5M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on BKYI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is BKYI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, BIO-key International Inc. (NASDAQ: BKYI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $2.70 (-7.85% 1D, market cap $5.5M). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 7/20. Across 714 tracked Technology issuers, BKYI ranks #525 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does BKYI compare to ORKT and LHSW in the Technology sector?

▼

Within the Technology sector (Computer Software: Prepackaged Software), BKYI carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 76.9%, and ROIC of -35.0%. By comparison, ORKT (Orangekloud Technology Inc. (Class A)) holds a E grade (30/100 RQD, P/E N/A, ROIC -35.0%, cap $5.8M) and LHSW (Lianhe Sowell International Group Ltd (Class A)) posts a E grade (31/100 RQD, P/E N/A, ROIC —, cap $5.9M). Among the 5-stock peer group, BKYI leads on earnings multiple (N/A) while BKYI leads on capital efficiency (-35.0% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for BKYI?

▼

Per BKYI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001019034), BIO-key International Inc. generated $5.9M in revenue (-14.3% YoY), $7.2M in net income, and -$4.7M in free cash flow against $8.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Technology with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.66 (-1.60%)🧬 Disciplined Float (+0.16% YoY Shares)⚙️ Cash Engine: 4/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (35/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.5% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-10.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BKYI)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (35/100 Composite)

🔍 WHY BKYI SCORES 35/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (29% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▲ #2 Bullish Driver: Macro Regime Fit+8/20 pts (23% of score)

FRED Regime × Technicals: 9% of 52W Range • RSI-14 at 50.8 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: Cash Engine Quality4/20 pts (-16 pt drag)

Capital intensity & 0% operating margin leave 16 pts on the table

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$2.83-18.7% Next Q

Q2 (-2Q)

Grade D$2.30+19.1% Next Q

Q3 (-1Q)

Grade E$2.74-1.5% Next Q

Current

Grade D-$2.70-8.5% Hist 90D α

Trajectory: D (43) → D- (35)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a BKYI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While BKYI currently carries a cautious 35/100 (D-) rating due to Cash Engine Quality (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Technology with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.57) and Max Pain ($2.84) forces dealer call-delta covering toward $14.49.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (+0.16% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $BKYI• $4.8M Crowd Pool • Kalshi / Polymarket Composite

Contract: “BKYI Beats Next Quarterly Revenue & EPS Consensus + Hyperscaler AI CapEx Holds Record Pace”

YES 35%NO 65%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

50.830 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCOREWEAK QUALITY (1–4)

4 / 99-Pt Accounting

52-WEEK LASER RANGE9% OF RANGE

L: $2$2.70H: $14

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: ERQD 4 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: ERQD 13 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: DRQD 18 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on BKYI

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (20)

-35.0% ROIC with 76.9% gross margin and 2.80% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BEARISH (50)

Altman-Z 4.20 and Piotroski 4/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (35)

13/40 institutional & smart-money positioning score with 8/20 macro alignment.

Bull Case: Why Buyers Like BKYI

✓Established market leader in Technology with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Sensitive to high interest rates and tighter Federal Reserve market liquidity.
!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BKYI)

✓Walkthrough of BKYI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

BKYI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -48.96%▼ DESCENDING CHANNEL

2026-11-03O $2.93H $2.93L $2.70C $2.70VOL 304.8K

RES: $4.05SUP: $0.76SMA50: $2.57SMA200: $4.53

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

BKYI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 BKYI Butterfly Map → + Track BKYI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on BKYI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for BKYI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for BKYI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BKYI)

Technology Rank #525 of 714 ⚔️ ORKT vs BKYI Full Matrix →

1. Head-to-Head Technology Peer Comparison (BKYI vs. ORKT, LHSW, GYGY, IFBD)

Industry: Computer Software: Prepackaged Software (222 Tracked Issuers)

Across 714 tracked Technology securities in the Roarable RQD universe, BIO-key International Inc. (BKYI) ranks #525 by composite RQD confidence (35/100, grade D-) and #668 by equity capitalization ($5.5M). Within this direct 5-issuer industry benchmark cohort, BKYI leads on earnings valuation at N/A trailing P/E, while BKYI leads on capital efficiency and profitability with -35.0% ROIC and 76.9% gross margin. BKYI currently leads its immediate peer cohort in composite quantitative strength at 35/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
BKYI ACTIVE BIO-key International Inc.	D-	35/100	—	76.9%	-35.0%	-7.85%	$5.5M	Benchmark Subject
ORKT Orangekloud Technology Inc. (Class A)	E	30/100	—	44.2%	-35.0%	0.00%	$5.8M	/orkt-vs-bkyi →
LHSW Lianhe Sowell International Group Ltd (Class A)	E	31/100	—	21.4%	—	-10.17%	$5.9M	/lhsw-vs-bkyi →
GYGY Game Your Game Inc.	E	27/100	—	8.6%	-35.0%	+6.93%	$6.0M	/gygy-vs-bkyi →
IFBD Infobird Co. Ltd	E	33/100	—	29.5%	-35.0%	+0.97%	$6.1M	/ifbd-vs-bkyi →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001019034

In its most recent audited fiscal period (FY2025, filed 2025-12-31), BIO-key International Inc. (BKYI) reported GAAP revenue of $5.9M (-14.3% vs. FY2024 revenue of $6.9M ) , GAAP net income of $7.2M, operating cash flow of -$4.7M, and free cash flow of -$4.7M (-59.9% YoY). On the balance sheet, BKYI closed FY2025 with $8.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$5.9M	$7.2M	-$4.7M	-$4.7M	$8.3M	—
FY2024 (FY)	2024-12-31	$6.9M	$4.3M	-$2.9M	-$2.9M	$8.6M	$44.8K
FY2023 (FY)	2023-12-31	$0	$8.5M	-$3.8M	-$3.8M	—	—

3. BKYI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is BKYI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does BKYI compare to ORKT and LHSW in the Technology sector?

What are the biggest fundamental strengths and SEC risk factors for BKYI?

Where is BKYI trading relative to its 50-day, 200-day, and 52-week technical levels?

BKYI last traded at $2.70 (-7.85% on volume of 304,782 shares), positioning the stock +5.06% above its 50-day simple moving average ($2.57) and -40.40% below its 200-day simple moving average ($4.53). Across its 52-week range of $1.55 to $13.80, BKYI sits at the 9.4% percentile with a 14-day RSI of 50.8 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($2.36 to $3.04).

BKYI Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell BKYI stock right now?

BIO-key International Inc. (BKYI) currently earns a Roarable Rating of D- (Sell — SELL) with 35/100 RQD Confidence. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.

What is BKYI's 12-month price target and RQD AI Jury consensus?

BKYI's 12-month base price target is $2.42 (range $1.89 to $14.49), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: BKYI RQD Cockpit BKYI 12M Forecast BKYI Earnings & Move BKYI Dividends & DRIP BKYI Insiders & 13F BKYI Whale Options BKYI Profit Sankey BKYI News & Why

ROARABLE RATING BRIEF • RQD 35/100 (D-) ✓ STAGE-C NUMBER FIREWALL VERIFIED

BKYI — BIO-key International Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:52:51Z

Roarable Rating Brief: What This Means to a Prospective Investor

Per the Roarable RQD rating, BKYI scores 38 out of 100, a letter grade of D-, with the verdict "Roarable Sell — Vulnerable Balance Sheet & Flow." The fundamental cash engine pillar scores 4 out of 20 (ROIC -35%; FCF yield 0%), indicating the business is not currently generating returns on invested capital or free cash flow available to shareholders. The whale 13F flow pillar scores 9 out of 20 (institutional accumulation and options positioning), which is weak support for the equity. The insider conviction pillar scores 7 out of 20 (SEC Form 4 and Congressional PTR cluster flow), signaling limited insider confidence in the source data. The macro regime fit pillar scores 8 out of 20 (beta 1.0; sector sensitivity). The forensic balance sheet pillar scores 10 out of 20 (Altman Z 2.5; Piotroski F 4/9; Debt/Equity 0.5), the strongest of the five but still below the midpoint. For a prospective investor, the upside case rests on a turnaround in operating economics that the current cash-flow metrics do not yet show, while valuation is difficult to anchor because earnings-based multiples are unavailable in the source data. The rating frames the stock as a sell-side risk profile on current evidence rather than a value opportunity.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$5.9M	$-6.8M	$7.2M	N/A	$-4.7M	$2.7M	N/A
FY 2024	$6.9M	$-4.0M	$4.3M	N/A	$-2.9M	$0.4M	$0.0M
FY 2023	$0.0M	$-8.8M	$8.5M	N/A	$-3.8M	N/A	N/A

Per the SEC financials, operating income is negative in every reported period, and free cash flow is negative in every period, while the reported net income figures are positive and diverge materially from operating results. Revenue declined from $6.9M in FY 2024 to $5.9M in FY 2025. Per the Roarable RQD rating, the Altman Z-Score is 2.5, the Piotroski F-Score is 4 out of 9, and Debt/Equity is 0.5. Cash rose to $2.7M in FY 2025 from $0.4M in FY 2024. ROIC is -35% per the market data.

Recent Catalysts & News Wire Analysis

Per the recent news wire, the principal catalyst is a reported new Middle East government security agency customer, which is also the headline of the most recent item and is flagged as a market wire story. A Cybersecurity-sector report flags a new security contract as a gain driver and carries a green catalyst light. Multiple market-wire items cover analyst ratings and why shares moved. A risk watch item is a short-interest report stating short interest at 71.29%, a level that signals heavy bearish positioning and potential squeeze volatility. Per the Butterfly Supply-Chain Graph, no proprietary signals are recorded.

Open Questions

What drives the gap between positive reported net income and negative operating income and free cash flow in every period?
What are the FY 2025 and FY 2024 EPS and debt figures, which are reported as N/A or $0.0M?
Will the reported Middle East government contract produce revenue in upcoming periods, and at what scale?
What explains the 52-week range from $1.55 to $13.8 relative to the current price of 2.93?
How will a 71.29% short interest level resolve against the company's cash position of $2.7M?

BKYI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for BIO-key International Inc. (BKYI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to BKYI Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo Finance • 15h ago

BIO-key Adds New Middle East Government Security Agency Customer, Expanding Regional Footprint

Yahoo Finance report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Moomoo • 18h ago

BIO-key International (BKYI) Stock Forecast & Analyst Ratings

Moomoo report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Investorideas.com • 21h ago

Cybersecurity Stock BIO-key International (NASDAQ: BKYI) Gains on New Security Contract

Investorideas.com report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE GuruFocus • 1d ago

BIO-key International (BKYI) Secures Major Middle East Governmen

GuruFocus report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance Singapore • 1d ago

Why Is BIO-key International Stock Surging Tuesday?

Yahoo Finance Singapore report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Quiver Quantitative • 1d ago

BIO-key International Stock Short Interest Rises to 71.29%

Quiver Quantitative report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST kalkine.ca • 1d ago

One-Day Penny Stock Surges: What Lifted BIO-key International (NASDAQ:BKYI) and XIAO-I (NASDAQ:AIXI)?

kalkine.ca report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST Timothy Sykes • 1d ago

BKYI Stock Surges As Gulf Partnership Ignites Trading Frenzy

Timothy Sykes report covering BIO-key International Inc. (BKYI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

BKYI Bull vs. Bear Conversation Board — What's Your Call at $2.70?

🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON BKYI 🐻 67% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH 🎯 Target: $2.58 (-11.9%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is BKYI (D- • RQD 38/100) a Buy at $2.93?

Welcome to the BKYI (BIO-key International Inc.) Roar Pit. Current RQD Composite is 38/100 (Roarable Sell — Vulnerable Balance Sheet & Flow) in Computer Software: Prepackaged Software. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

RI RiskArb_Desk Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $2.20 (-24.9%)

Spot @ $2.93

Pump the brakes on BKYI — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on BKYI, but look at what you are paying: current EV/EBITDA multiples with 76.9% gross margins. Unless BIO-key International Inc. expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

TA TapeReader_Pro Verified K Arena Trader 🐂 BULLISH 🎯 Target: $3.75 (+28.0%)

Spot @ $2.93

BKYI cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on BKYI, the market is fixating on short-term headline noise in Computer Software: Prepackaged Software and ignoring the balance sheet and cash flow trajectory. At $2.93 (52-wk range $1.55 - $13.80), any beat on forward guidance forces shorts and underweight funds to chase.